Home » Authors » Mark McCarty

Articles by Mark McCarty

SEC's Treadway group issues new small-cap SOX guidance

July 13, 2006

By Mark McCarty

Panel: U.S. universal coverage will come with less med-tech

July 13, 2006

By Mark McCarty

Moratorium on Medicare cuts for imaging eyed in H.R. 5704

July 13, 2006

By Mark McCarty

FDA to roll out 'track-and-trace' for drugs; devices may follow

July 12, 2006

By Mark McCarty

Internet seen as conduit for best-practices dissemination

July 11, 2006

By Mark McCarty

Panel: U.S. universal coverage will come with less med-tech

July 10, 2006

By Mark McCarty

HSAs: fairly traditional coverage – or 'extra dollars for the rich'?

July 6, 2006

By Mark McCarty

Moratorium on Medicare cuts for imaging eyed in H.R. 5704

July 6, 2006

By Mark McCarty

New FDA guidances aimed at reducing 'gridlock' of trials

July 5, 2006

By Mark McCarty

Risk analysis role in ICD implantation decision is debated

July 1, 2006

By Mark McCarty

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...